Literature DB >> 4404827

Determination of antibody to pneumococcal polysaccharides with chromic chloride-treated human red blood cells and indirect hemagglutination.

A J Ammann, R J Pelger.   

Abstract

A method is described for the quantitation of serum antibody to type-specific pneumococcal polysaccharide. The method uses highly purified pneumococcal polysaccharide coated onto human O+ red blood cells by the chromic chloride technique. Each of 14 pneumococcal polysaccharide types was individually coated onto red blood cells and used to determine the antibody response following primary immunization. The method was found to be sensitive, detecting antibody titer increases of several hundred to a thousand-fold. The presence of high preimmunization antibody titers did not obscure the detection of antibody titer increases. The method detected antibody of both the immunoglobulin M and immunoglobulin G class when quantitated after ultracentrifugation and sucrose density gradient separation. By using serum samples obtained from volunteers immunized with a single pneumococcal polysaccharide, the method was standardized resulting in an ability to compare samples taken at different times and obtained from different sources. The method appears to be simple, reproducible, and inexpensive and can be utilized to determine the antibody response following immunization in large population studies.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4404827      PMCID: PMC380644          DOI: 10.1128/am.24.5.679-683.1972

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  9 in total

1.  Chromic chloride: a coupling reagent for passive hemagglutination reactions.

Authors:  E R Gold; H H Fudenberg
Journal:  J Immunol       Date:  1967-11       Impact factor: 5.422

2.  Increased resistance to penicillin of pneumococci isolated from man.

Authors:  D Hansman; H Glasgow; J Sturt; L Devitt; R Douglas
Journal:  N Engl J Med       Date:  1971-01-28       Impact factor: 91.245

3.  Deficiency of pneumococcal serum opsonizing activity in sickle-cell disease.

Authors:  J A Winkelstein; R H Drachman
Journal:  N Engl J Med       Date:  1968-08-29       Impact factor: 91.245

4.  Anaphylactoid transfusion reactions associated with anti-IgA.

Authors:  G N Vyas; H A Perkins; H H Fudenberg
Journal:  Lancet       Date:  1968-08-10       Impact factor: 79.321

5.  A new rapid method for genetic typing of human immunoglobulins.

Authors:  G N Vyas; H H Fudenberg; H M Pretty; E R Gold
Journal:  J Immunol       Date:  1968-02       Impact factor: 5.422

6.  Splenectomy in childhood and the hazard of overwhelming infection.

Authors:  L K Diamond
Journal:  Pediatrics       Date:  1969-05       Impact factor: 7.124

7.  Otitis media: a clinical and bacteriological correlation.

Authors:  V M Howie; J H Ploussard; R L Lester
Journal:  Pediatrics       Date:  1970-01       Impact factor: 7.124

8.  Passive immune lysis with chromic chloride-treated erythrocytes.

Authors:  P J Perucca; W P Faulk; H H Fudenberg
Journal:  J Immunol       Date:  1969-04       Impact factor: 5.422

9.  Use of erythrocytes sensitized with purified pneumococcal polysaccharides for the assay of antibody and antibody-producing cells.

Authors:  P J Baker; P W Stashak; B Prescott
Journal:  Appl Microbiol       Date:  1969-03
  9 in total
  20 in total

1.  Classical and alternative complement pathway activation by pneumococci.

Authors:  C G Stephens; R C Williams; W P Reed
Journal:  Infect Immun       Date:  1977-08       Impact factor: 3.441

Review 2.  Anti-pneumococcal antibody titre measurement: what useful information does it yield?

Authors:  Paul Balmer; Andrew J Cant; Ray Borrow
Journal:  J Clin Pathol       Date:  2006-09-01       Impact factor: 3.411

Review 3.  Measuring immune responses to pneumococcal vaccines.

Authors:  David C LaFon; Moon H Nahm
Journal:  J Immunol Methods       Date:  2018-08-08       Impact factor: 2.303

4.  Antigenicity of type-specific pneumococcal polysaccharides in rats.

Authors:  J D Coonrod; B Rylko-Bauer
Journal:  Infect Immun       Date:  1976-06       Impact factor: 3.441

5.  Complement-fixing antibody response in pneumococcal pneumonia.

Authors:  J D Coonrod; B Rylko-Bauer
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

6.  Assessment of cellular and humoral immunity of myasthenics.

Authors:  S W Huang; J W Rose; R F Mayer
Journal:  J Neurol Neurosurg Psychiatry       Date:  1977-11       Impact factor: 10.154

7.  Detection of antibodies to pneumococcal capsular polysaccharides by enzyme-linked immunosorbent assay.

Authors:  F K Pedersen; J Henrichsen
Journal:  J Clin Microbiol       Date:  1982-03       Impact factor: 5.948

8.  Determination of antibodies to pneumococcal C polysaccharide in patients with community-acquired pneumonia.

Authors:  H Holmberg; A Krook; A M Sjögren
Journal:  J Clin Microbiol       Date:  1985-11       Impact factor: 5.948

9.  Pneumococcal antibody levels in patients with acute lung infiltrates.

Authors:  A Löwenberg; J A Snijder; L T vd Weele; H J Sluiter
Journal:  Infection       Date:  1987 May-Jun       Impact factor: 3.553

10.  Specificity of immunoglobulin M antibodies in normal human serum that participate in opsonophagocytosis and intracellular killing of Bacteroides fragilis and Bacteroides thetaiotaomicron by by human polymorphonuclear leukocytes.

Authors:  A B Bjornson; H S Bjornson; B P Kitko
Journal:  Infect Immun       Date:  1980-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.